Other therapy.
Genomically Basal-Type tumors demonstrate distinct immune profiles and chemosensitivity across self-reported race among patients enrolled in FLEX receiving neoadjuvant chemotherapy
Publication: ASBrS 2026, Abstract Number: 1062 Authors:Nathalie Johnson, Mehran Read More